The ORVAC trial: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis: a statistical analysis plan

Mark A. Jones, Todd Graves, Bianca Middleton, James Totterdell, Thomas L. Snelling, Julie A. Marsh

Research output: Contribution to journalArticlepeer-review

15 Downloads (Pure)

Fingerprint

Dive into the research topics of 'The ORVAC trial: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis: a statistical analysis plan'. Together they form a unique fingerprint.

Medicine & Life Sciences